A Pilot Trial Evaluating Meta050, a Proprietary Combination of Reduced Iso-Alpha Acids, Rosemary Extract and Oleanolic Acid in Patients With Arthritis and Fibromyalgia.

Lukaczer Daniel, et al.
Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 2005

Abstract

The aim of this open-label, 8-week observational trial was to investigate the efficacy of Meta050 (a proprietary, standardized combination of reduced iso-alpha-acids from hops, rosemary extract and oleanolic acid) on pain in patients with rheumatic disease. Osteoarthritis, rheumatoid arthritis and fibromyalgia patients were given 440 mg Meta050 three times a day for 4 weeks, which was changed to 880 mg twice a day for the subsequent 4 weeks in the majority of patients. Pain and condition-specific symptoms were assessed using a standard visual analog scale (VAS), an abridged arthritis impact measurement scale (AIMS2) and the fibromyalgia impact questionnaire. Fifty-four subjects with rheumatic disease completed the trial. Following treatment, a statistically significant decrease in pain of 50% and 40% was observed in arthritis subjects using the VAS (p < 0.0001; Wilcoxon-ranked sums) and AIMS2 (p < 0.0001), respectively. Fibromyalgia subject scores did not significantly improve. A decreasing trend of C-reactive protein, a marker for inflammation, was also observed in those subjects who presented with elevated C-reactive protein. No serious side effects were observed. These observations suggest that Meta050 at a dosage of 440 mg three times a day has a beneficial effect on pain in arthritis subjects.

Copyright (c) 2005 John Wiley & Sons, Ltd.

Articles similar to "A Pilot Trial Evaluating Meta050, a Proprietary Combination of Reduced Iso-Alpha Acids, Rosemary Extract and Oleanolic Acid in Patients With Arthritis and Fibromyalgia."

• The impact of Rosmarinus Officinalis on Arthritis / Joint Pain: Inhibition of Complement by Covalent Attachment of Rosmarinic Acid to Activated C3b. (Rosmarinic acid has been reported to inhibit complement activation in vivo as well as in vitro...)
• The significance of Rosmarinus Officinalis for Arthritis / Joint Pain: Protective Action of Ethanolic Extract of Rosmarinus Officinalis L. In Gastric Ulcer Prevention Induced by Ethanol in Rats. (The pathology of a gastric ulcer is complex and multifactorial...)

Previous article

Pharmacology of Rosemary (Rosmarinus Officinalis Linn.) and Its Therapeutic Potentials.

Next article

Inhibition of Complement by Covalent Attachment of Rosmarinic Acid to Activated C3b.